Israel - English - Ministry of Health

padagis israel agencies ltd, israel - temozolomide - capsules - temozolomide 20 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - temozolomide - capsules - temozolomide 100 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - temozolomide - capsules - temozolomide 100 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - temozolomide - capsules - temozolomide 250 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - temozolomide - capsules - temozolomide 250 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - bupivacaine - bupivacaine - spinal anaesthesia for surgery.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - benzoyl peroxide as hydrous; clindamycin as phosphate - gel - clindamycin as phosphate 1 %w/w; benzoyl peroxide as hydrous 5 %w/w - clindamycin - clindamycin - mild to moderate acne vulgaris, particulary inflammatory lesions.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - benzoin siam; hamamelis; ichthammol; titanium dioxide; zinc oxide - ointment - ichthammol 1.474 g / 100 g; zinc oxide 14.763 g / 100 g; hamamelis 0.984 g / 100 g; benzoin siam 0.1 g / 100 g; titanium dioxide 5.905 g / 100 g - other anti-acne preparations for systemic use - local treatment of eczema, feet ulcers, mild burns and skin irritations.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - atracurium besylate - solution for injection - atracurium besylate 10 mg/ml - atracurium - atracurium - atracurium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation.

United States - English - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 100 mg in 5 ml - carefully consider the potential benefits and risks of ibuprofen oral suspension and other treatment options before deciding to use ibuprofen oral suspension. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). in pediatric patients, ibuprofen oral suspension is indicated: in adults, ibuprofen oral suspension is indicated: since there have been no controlled trials to demonstrate whether there is any beneficial effect or harmful interaction with the use of ibuprofen in conjunction with aspirin, the combination cannot be recommended (see precautions - drug interactions ). ibuprofen oral suspension is contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen oral suspension should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings